Characterization of the hypothalamic proopiomelanocortin gene and β-endorphin expression in the hypothalamic arcuate nucleus of mice elicited by inflammatory pain

Neuroscience

Volumn 152, Issue 4, 2008, Pages 1054-1066

  Seo, Y J ^a   Kwon, M S ^a   Choi, S S ^b   Han, E J ^a   Jung, J S ^a   Choi, H W ^a   Park, S H ^a   Jang, J E ^a   Suh, H W ^a  

^a Hallym University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

beta endorphin; hypothalamus; inflammatory pain; proopiomelanocortin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BETA ENDORPHIN; FORMALDEHYDE; GLUTAMIC ACID; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PROOPIOMELANOCORTIN; PROTEIN KINASE (CALCIUM,CALMODULIN) II; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARCUATE NUCLEUS; ARTICLE; GENE EXPRESSION; HYPOTHALAMUS; IMMUNOREACTIVITY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; ARCUATE NUCLEUS; BETA-ENDORPHIN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; FORMALDEHYDE; GENE EXPRESSION REGULATION; I-KAPPA B PROTEINS; MALE; MICE; MICE, INBRED ICR; PAIN; PRO-OPIOMELANOCORTIN; RNA, MESSENGER; TIME FACTORS;

EID: 41549129801     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.06.047     Document Type: Article

References (54)

1. Behbehani M.M. Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol 46 (1995) 575-605
2. Boutillier A.L., Gaiddon C., Lorang D., Roberts J.L., and Loeffler J.P. Transcriptional activation of the proopiomelanocortin gene by cyclic AMP-responsive element binding protein. Pituitary 1 (1998) 33-43
3. Bronstein D.M., Schafer M.K., Watson S.J., and Akil H. Evidence that beta-endorphin is synthesized in cells in the nucleus tractus solitarius: detection of POMC mRNA. Brain Res 587 (1992) 269-275
4. Carrasquillo Y., and Gereau R.W. Activation of the extracellular signal-regulated kinase in the amygdala modulates pain perception. J Neurosci 27 (2007) 1543-1551
5. 2+/calmodulin-dependent protein kinase II and phosphorylated extracellular signal-regulated protein in the mouse formalin pain model. Brain Res 1108 (2006) 28-38
6. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
7. Civelli O., Birnberg N., and Herbert E. Detection and quantitation of pro-opiomelanocortin mRNA in pituitary and brain tissues from different species. J Biol Chem 257 (1982) 6783-6787
8. Coderre T.J., and Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12 (1992) 3665-3670
9. Danielson P.E., Forss-Petter S., Brow M.A., Calavetta L., Douglass J., Milner R.J., and Sutcliffe J.G. p1B15: A cDNA clone of the rat mRNA encoding cyclophilin. DNA 7 (1988) 261-267
10. Dave J.R., Eiden L.E., Lozovsky D., Waschek J.A., and Eskay R.L. Calcium-independent and calcium-dependent mechanisms regulate corticotropin-releasing factor-stimulated proopiomelanocortin peptide secretion and messenger ribonucleic acid production. Endocrinology 120 (1987) 305-310
11. Drouin J., Sun Y.L., Chamberland M., Gauthier Y., De Lean A., Nemer M., and Schmidt T.J. Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J 12 (1993) 145-156
12. Dubuisson D., and Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4 (1977) 161-174
13. Eipper B.A., and Mains R.E. Further analysis of post-translational processing of beta-endorphin in rat intermediate pituitary. J Biol Chem 256 (1981) 5689-5695
14. Facchinetti F., Tassinari G., Porro C.A., Galetti A., and Genazzani A.R. Central changes of beta-endorphin-like immunoreactivity during rat tonic pain differ from those of purified beta-endorphin. Pain 49 (1992) 113-116
15. Howe C.J., LaHair M.M., Maxwell J.A., Lee J.T., Robinson P.J., Rodriguez-Mora O., McCubrey J.A., and Franklin R.A. Participation of the calcium/calmodulin-dependent kinases in hydrogen peroxide-induced Ikappa B phosphorylation in human T lymphocytes. J Biol Chem 277 (2002) 30469-30476
16. Hudson P., Penschow J., Shine J., Ryan G., Niall H., and Coghlan J. Hybridization histochemistry: use of recombinant DNA as a 'homing probe' for tissue localization of specific mRNA populations. Endocrinology 108 (1981) 353-356
17. Hunskaar S., and Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30 (1987) 103-114
18. Hunskaar S., Fasmer O.B., and Hole K. Formalin test in mice, a useful technique for evaluating mild analgesics. J Neurosci Methods 14 (1985) 69-76
19. Hunt S.P., and Mantyh P.W. The molecular dynamics of pain control. Nat Rev Neurosci 2 (2001) 83-91
20. Hylden J.L., and Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67 (1980) 313-316
21. Hylden J.L., and Wilcox G.L. Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res 217 (1981) 212-215
22. Kaltschmidt C., Kaltschmidt B., Neumann H., Wekerle H., and Baeuerle P.A. Constitutive NF-kappa B activity in neurons. Mol Cell Biol 14 (1994) 3981-3992
23. Karin M., and Delhase M. JNK or IKK, AP-1 or NF-kappaB: which are the targets for MEK kinase 1 action?. Proc Natl Acad Sci U S A 95 (1998) 9067-9069
24. Kovalovsky D., Refojo D., Liberman A.C., Hochbaum D., Pereda M.P., Coso O.A., Stalla G.K., Holsboer F., and Arzt E. Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. Mol Endocrinol 16 (2002) 1638-1651
25. Krieger D.T., Liotta A., and Brownstein M.J. Presence of corticotropin in limbic system of normal and hypophysectomized rats. Brain Res 128 (1977) 575-579
26. Krieger D.T., Liotta A., and Brownstein M.J. Presence of corticotropin in brain of normal and hypophysectomized rats. Proc Natl Acad Sci U S A 74 (1977) 648-652
27. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
28. Laursen S.E., and Belknap J.K. Intracerebroventricular injections in mice. Some methodological refinements. J Pharmacol Methods 16 (1986) 355-357
29. Liotta A.S., Gildersleeve D., Brownstein M.J., and Krieger D.T. Biosynthesis in vitro of immunoreactive 31,000-dalton corticotropin/beta-endorphin-like material by bovine hypothalamus. Proc Natl Acad Sci U S A 76 (1979) 1448-1452
30. Mansour A., Fox C.A., Akil H., and Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18 (1995) 22-29
31. Mao J., Price D.D., and Mayer D.J. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62 (1995) 259-274
32. Mao J., Price D.D., Hayes R.L., Lu J., and Mayer D.J. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. Brain Res 598 (1992) 271-278
33. Millan M.J. Multiple opioid systems and pain. Pain 27 (1986) 303-347
34. Millan M.J. Descending control of pain. Prog Neurobiol 66 (2002) 355-474
35. Murphy E.P., and Conneely O.M. Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors. Mol Endocrinol 11 (1997) 39-47
36. Murray C.W., Cowan A., and Larson A.A. Neurokinin and NMDA antagonists (but not a kainic acid antagonist) are antinociceptive in the mouse formalin model. Pain 44 (1991) 179-185
37. Philips A., Maira M., Mullick A., Chamberland M., Lesage S., Hugo P., and Drouin J. Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol Cell Biol 17 (1997) 5952-5959
38. Philips A., Lesage S., Gingras R., Maira M.H., Gauthier Y., Hugo P., and Drouin J. Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol Cell Biol 17 (1997) 5946-5951
39. Porro C.A., Tassinari G., Facchinetti F., Panerai A.E., and Carli G. Central beta-endorphin system involvement in the reaction to acute tonic pain. Exp Brain Res 83 (1991) 549-554
40. Porro C.A., Cavazzuti M., Lui F., Giuliani D., Pellegrini M., and Baraldi P. Independent time courses of supraspinal nociceptive activity and spinally mediated behavior during tonic pain. Pain 104 (2003) 291-301
41. Rivier C., Brownstein M., Spiess J., Rivier J., and Vale W. In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology 110 (1982) 272-278
42. Roberts J.L., Phillips M., Rosa P.A., and Herbert E. Steps involved in the processing of common precursor forms of adrenocorticotropin and endorphin in cultures of mouse pituitary cells. Biochemistry 17 (1978) 3609-3618
43. Rubinstein M., Mogil J.S., Japon M., Chan E.C., Allen R.G., and Low M.J. Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis. Proc Natl Acad Sci U S A 93 (1996) 3995-4000
44. Skilling S.R., Smullin D.H., Beitz A.J., and Larson A.A. Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation. J Neurochem 51 (1988) 127-132
45. Sun Y.G., Lundeberg T., and Yu L.C. Involvement of endogenous beta-endorphin in antinociception in the arcuate nucleus of hypothalamus in rats with inflammation. Pain 104 (2003) 55-63
46. Takahashi N., Hayano T., and Suzuki M. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 337 (1989) 473-475
47. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76 (1979) 4350-4354
48. Tseng L.F. Evidence for epsilon-opioid receptor-mediated beta-endorphin-induced analgesia. Trends Pharmacol Sci 22 (2001) 623-630
49. Widmaier E.P., and Dallman M.F. The effects of corticotropin-releasing factor on adrenocorticotropin secretion from perifused pituitaries in vitro: rapid inhibition by glucocorticoids. Endocrinology 115 (1984) 2368-2374
50. Winzer-Serhan U.H., and Leslie F.M. Codistribution of nicotinic acetylcholine receptor subunit alpha3 and beta4 mRNAs during rat brain development. J Comp Neurol 386 (1997) 540-554
51. Wu H., Hung K., Ohsawa M., Mizoguchi H., and Tseng L.F. Antisera against endogenous opioids increase the nocifensive response to formalin: demonstration of inhibitory beta-endorphinergic control. Eur J Pharmacol 421 (2001) 39-43
52. Yamamoto T., and Yaksh T.L. Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists. Pain 49 (1992) 121-128
53. Zakarian S., and Smyth D.G. Distribution of beta-endorphin-related peptides in rat pituitary and brain. Biochem J 202 (1982) 561-571
54. Zangen A., Herzberg U., Vogel Z., and Yadid G. Nociceptive stimulus induces release of endogenous beta-endorphin in the rat brain. Neuroscience 85 (1998) 659-662